Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer‐BioNTech mRNA COVID‐19 vaccine administration
Open Access
- 4 October 2021
- journal article
- case report
- Published by Wiley in Respirology Case Reports
- Vol. 9 (11) , e0860
Abstract
The global effects of coronavirus disease 2019 (COVID‐19) have driven unprecedented rapid development and mass deployment of vaccinations against the novel coronavirus. However, the short‐ and long‐term adverse reactions following COVID‐19 vaccinations are still under investigation as insufficient time has passed to fully explore these. The Pfizer‐BioNTech COVID‐19 mRNA vaccine has thus far shown a favourable safety profile in phase I–III studies. Although infrequent cases of generalized cutaneous reactions and systemic inflammatory response have been reported following other mRNA vaccines, these have not been reported following the Pfizer‐BioNTech vaccine. We report a case of generalized lichenoid skin eruptions and systemic inflammatory response occurring together following the first dose of the Pfizer‐BioNTech vaccine. Our case report adds to an accumulating body of literature connecting autoimmunity with the pathophysiology of the novel coronavirus disease.Keywords
This publication has 9 references indexed in Scilit:
- Myocarditis and pericarditis after vaccination for COVID‐19JACEP Open, 2021
- Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 casesJournal of the American Academy of Dermatology, 2021
- A Case of Postural Orthostatic Tachycardia Syndrome Secondary to the Messenger RNA COVID-19 VaccineCureus, 2021
- Persistent maculopapular rash after the first dose of Pfizer‐BioNTech COVID‐19 vaccineJournal of the European Academy of Dermatology and Venereology, 2021
- 18F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccineThe Lancet, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccineDermatology Online Journal, 2021
- Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategiesClinical Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020